(Q38994946)

English

The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks

scientific article published on 17 June 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Yusuf Baran

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

author name string

Aysun Adan

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

17 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

8973-8984

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Understanding the molecular pathogenesis of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Current treatment strategy of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Apoptosis by dietary agents for prevention and treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Flavonoids as prospective compounds for anti-cancer therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin: a dietary antioxidant for health promotion

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Dietary agents for chemoprevention of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Dietary flavonoid fisetin: a novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Involvement of the ERK signaling pathway in fisetin reduces invasion and migration in the human lung cancer cell line A549.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Rutinoside at C7 attenuates the apoptosis-inducing activity of flavonoids

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Role of hesperetin (a natural flavonoid) and its analogue on apoptosis in HT-29 human colon adenocarcinoma cell line--a comparative study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Hesperetin induced G1-phase cell cycle arrest in human breast cancer MCF-7 cells: involvement of CDK4 and p21.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin induces apoptosis in human nonsmall lung cancer cells via a mitochondria-mediated pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

The apoptotic effect of hesperetin on human cervical cancer cells is mediated through cell cycle arrest, death receptor, and mitochondrial pathways

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin inhibits growth, induces G₂ /M arrest and apoptosis of human epidermoid carcinoma A431 cells: role of mitochondrial membrane potential disruption and consequent caspases activation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Identification of novel differentially expressed genes by the effect of a high-fat n-6 diet in experimental breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

SASH1 regulates proliferation, apoptosis, and invasion of osteosarcoma cell

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Tumoral and tissue-specific expression of the major human beta-tubulin isotypes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

c-Myc target genes involved in cell growth, apoptosis, and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3597-6

21 January 2018

Suppression of tumorigenesis in mitochondrial NADP(+)-dependent isocitrate dehydrogenase knock-out mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship between metallothionein-1F (MT1F) gene and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26081618

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-015-3597-6

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38994946&oldid=2202439295"